Dr. Aung has 20 years of experience in the biotechnology and pharmaceutical industry and has led oncology-focused clinical development teams and projects, according to a Feb. 3 news release from the company.
In her new role, Dr. Aung will lead the development of several Ambrx product candidates.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
